TrialCritical care explorations2025

Evaluation of Plasma Biomarkers to Understand the Biology and Heterogeneity of Treatment Effect in Lower Tidal Volume Ventilation Facilitated by Extracorporeal CO2 Removal in Acute Hypoxemic Respiratory Failure: A Secondary Analysis of the REST Trial.

Andrew J Boyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.